Luc Mainville, Interim Chief Executive Officer at Acerus Pharmaceuticals, holds 4.31M shares in ChitogenX (Ticker: CHNXF), holds 875.00K shares in LSL Pharma Group Inc (Ticker: TSE:LSL), holds 3.04M shares in Valeo Pharma (Ticker: VPHIF). Most recently, Luc Mainville Sold ― shares of ChitogenX on Nov 20, 2024 for an estimated value of 3.55K.
Luc Mainville latest transaction was an Informative Sell of $3.55K.
What was Luc Mainville's most profitable transaction?
Luc Mainville’s most profitable transaction was an Informative Buy of ASPCQ stock on December 9, 2016. The return on the trade was 187.80%.
What is Luc Mainville's role in Acerus Pharmaceuticals?
Luc Mainville's role in Acerus Pharmaceuticals is Interim Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.